Related Experiment Video
Updated: Aug 11, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
Ca2+ and Mg2+ selectively induce aggregates of PHF-tau but not normal human tau
1Department of Pathology, Albert Einstein College of Medicine, Bronx, New York 10461, USA. lyang@aecom.yu.edu
Abstract:
The molecular mechanism of pathological aggregation of microtubule-associated protein tau during neurodegeneration is unclear. In the present study, the in vitro effect of various metal ions on the aggregation of tau was examined using paired helical filament tau (PHF-tau) obtained from corticobasal degeneration (CBD) and Alzheimer's disease (AD) brains as well as normal human tau proteins isolated from fetal and adult brains and a recombinant system. Among the metal ions tested, Ca2+ and Mg2+ effectively induced formation of approximately 340 kD aggregates of PHF-tau but not normal tau proteins as determined by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and immunoblotting. Al3+ and Fe2+ precipitated both PHF-tau and normal tau protein as SDS-insoluble pellets. The other metal ions examined (Cu2+, Zn2+, and Li+) were inactive and caused neither aggregation nor precipitation of any tau protein. Intermixing experiments using PHF-tau and various normal tau preparations showed that the 340-kD aggregates induced by Ca2+ contained PHF-tau but not normal tau regardless whether unmodified (recombinant) or highly phosphorylated (fetal brain) tau proteins were used. The present results suggest that post-translational modifications other than the fetal-type phosphorylation are required for Ca2+- and Mg2+-dependent aggregation of PHF-tau and that the regional elevation of these ions may trigger pathological deposition of PHF-tau in certain neurodegenerative disorders.
Insights
Metal ions like calcium (Ca2+) and magnesium (Mg2+) can trigger the aggregation of pathological tau protein (PHF-tau), a key factor in neurodegenerative diseases like Alzheimer's disease.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Pathological aggregation of microtubule-associated protein tau (PHF-tau) is a hallmark of neurodegenerative diseases.
- The precise molecular mechanisms driving tau aggregation remain incompletely understood.
Purpose of the Study:
- To investigate the in vitro effects of various metal ions on the aggregation of normal and pathological tau proteins.
- To elucidate the role of specific metal ions in the formation of PHF-tau aggregates.
Main Methods:
- Utilized paired helical filament tau (PHF-tau) from Alzheimer's disease (AD) and corticobasal degeneration (CBD) brains, alongside normal human tau from fetal and adult brains and a recombinant system.
- Employed sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and immunoblotting to analyze protein aggregation and precipitation.
- Conducted intermixing experiments to determine the composition of induced aggregates.
Main Results:
- Calcium (Ca2+) and magnesium (Mg2+) ions specifically induced aggregation of PHF-tau, forming ~340 kD aggregates, but did not affect normal tau.
- Aluminum (Al3+) and iron (Fe2+) ions precipitated both PHF-tau and normal tau into SDS-insoluble pellets.
- Copper (Cu2+), zinc (Zn2+), and lithium (Li+) ions showed no effect on tau aggregation or precipitation.
- Ca2+-induced aggregates contained PHF-tau, excluding both unmodified recombinant and phosphorylated fetal tau, indicating the necessity of specific post-translational modifications.
Conclusions:
- Ca2+ and Mg2+ ions play a significant role in the aggregation of PHF-tau, distinct from their effect on normal tau.
- Post-translational modifications, beyond fetal-type phosphorylation, are crucial for Ca2+- and Mg2+-dependent PHF-tau aggregation.
- Elevated regional concentrations of Ca2+ and Mg2+ may act as triggers for pathological PHF-tau deposition in neurodegenerative disorders.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Alzheimer Disease ll: Pathophysiology

